Marpai (MRAI) Competitors $1.02 -0.01 (-0.97%) As of 01/17/2025 03:54 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends MRAI vs. ENZ, TOI, CCM, ATIP, BRTX, KDLY, ATPC, OTRK, OPGN, and MGRXShould you be buying Marpai stock or one of its competitors? The main competitors of Marpai include Enzo Biochem (ENZ), Oncology Institute (TOI), Concord Medical Services (CCM), ATI Physical Therapy (ATIP), BioRestorative Therapies (BRTX), Kindly MD (KDLY), Agape ATP (ATPC), Ontrak (OTRK), OpGen (OPGN), and Mangoceuticals (MGRX). These companies are all part of the "healthcare" industry. Marpai vs. Enzo Biochem Oncology Institute Concord Medical Services ATI Physical Therapy BioRestorative Therapies Kindly MD Agape ATP Ontrak OpGen Mangoceuticals Enzo Biochem (NYSE:ENZ) and Marpai (NASDAQ:MRAI) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations. Do analysts rate ENZ or MRAI? Marpai has a consensus price target of $6.00, indicating a potential upside of 488.24%. Given Marpai's stronger consensus rating and higher possible upside, analysts clearly believe Marpai is more favorable than Enzo Biochem.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enzo Biochem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Marpai 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community believe in ENZ or MRAI? Enzo Biochem received 210 more outperform votes than Marpai when rated by MarketBeat users. However, 66.67% of users gave Marpai an outperform vote while only 54.22% of users gave Enzo Biochem an outperform vote. CompanyUnderperformOutperformEnzo BiochemOutperform Votes21254.22% Underperform Votes17945.78% MarpaiOutperform Votes266.67% Underperform Votes133.33% Which has preferable earnings and valuation, ENZ or MRAI? Enzo Biochem has higher earnings, but lower revenue than Marpai. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnzo Biochem$31.91M1.07-$26.08MN/AN/AMarpai$37.15M0.39-$28.75M-$2.64-0.39 Does the media prefer ENZ or MRAI? In the previous week, Enzo Biochem had 8 more articles in the media than Marpai. MarketBeat recorded 8 mentions for Enzo Biochem and 0 mentions for Marpai. Enzo Biochem's average media sentiment score of 0.20 beat Marpai's score of 0.00 indicating that Enzo Biochem is being referred to more favorably in the media. Company Overall Sentiment Enzo Biochem Neutral Marpai Neutral Do insiders and institutionals hold more shares of ENZ or MRAI? 36.9% of Enzo Biochem shares are owned by institutional investors. Comparatively, 49.8% of Marpai shares are owned by institutional investors. 11.4% of Enzo Biochem shares are owned by insiders. Comparatively, 61.3% of Marpai shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is ENZ or MRAI more profitable? Enzo Biochem has a net margin of -75.34% compared to Marpai's net margin of -85.70%. Marpai's return on equity of 0.00% beat Enzo Biochem's return on equity.Company Net Margins Return on Equity Return on Assets Enzo Biochem-75.34% -7.96% -5.49% Marpai -85.70%N/A -100.23% Which has more risk and volatility, ENZ or MRAI? Enzo Biochem has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500. Comparatively, Marpai has a beta of 5.03, suggesting that its stock price is 403% more volatile than the S&P 500. SummaryMarpai beats Enzo Biochem on 9 of the 16 factors compared between the two stocks. Get Marpai News Delivered to You Automatically Sign up to receive the latest news and ratings for MRAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRAI vs. The Competition Export to ExcelMetricMarpaihealth & allied services, not elsewhere classified IndustryBusiness SectorNASDAQ ExchangeMarket Cap$14.57M$2.16B$7.47B$9.14BDividend YieldN/A8.00%2.32%4.02%P/E RatioN/A16.7527.9517.09Price / Sales0.397.53103.3177.22Price / CashN/A9.3729.3736.04Price / Book-0.593.156.194.79Net Income-$28.75M$65.07M$134.52M$224.99M7 Day Performance-1.92%2.49%2.65%2.37%1 Month Performance3.82%8.74%5.01%4.40%1 Year Performance-12.07%-16.52%24.01%20.10% Marpai Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRAIMarpaiN/A$1.02-1.0%$6.00+488.2%-12.1%$14.57M$37.15M0.00150Gap DownENZEnzo Biochem1.687 of 5 stars$0.66-3.4%N/A-51.8%$34.32M$30.31M0.00520Analyst ForecastGap UpTOIOncology Institute2.5038 of 5 stars$0.31+3.3%$2.50+702.1%-74.3%$23.55M$324.24M-0.40660Gap UpCCMConcord Medical Services0.6463 of 5 stars$4.51-2.4%N/A-52.3%$19.58M$471.70M0.00970Analyst ForecastGap DownATIPATI Physical TherapyN/A$2.63+0.4%N/A-80.3%$11.60M$741.86M-0.145,600High Trading VolumeBRTXBioRestorative Therapies3.9412 of 5 stars$1.56-4.3%$18.00+1,053.8%+25.5%$10.80M$377,000.00-1.027Positive NewsGap UpKDLYKindly MDN/A$1.44+0.8%N/AN/A$8.62M$2.88M0.00N/APositive NewsGap DownATPCAgape ATP0.2016 of 5 stars$1.97+56.3%N/A-85.9%$7.86M$1.35M-2.7040Gap UpHigh Trading VolumeOTRKOntrak2.6671 of 5 stars$1.79+1.0%$45.00+2,416.4%-54.5%$7.54M$11.24M-0.17250OPGNOpGenN/A$0.80+1.3%N/A-31.8%$6.69M$2.67M0.00100Analyst ForecastNews CoverageMGRXMangoceuticals1.3999 of 5 stars$2.60-2.6%N/A-96.4%$6.47M$755,000.00-0.453Positive News Related Companies and Tools Related Companies Enzo Biochem Competitors Oncology Institute Competitors Concord Medical Services Competitors ATI Physical Therapy Competitors BioRestorative Therapies Competitors Kindly MD Competitors Agape ATP Competitors Ontrak Competitors OpGen Competitors Mangoceuticals Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MRAI) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marpai, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marpai With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
